World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
91191
World Ranking
2649
National Ranking
1481

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John F. DiPersio is affiliated with Washington University in St. Louis in the United States. Their research primarily focuses on medicine, with extensive publications in hematology, oncology, immunology, molecular biology, and genetics.

The scientist's work covers several main topics, including:

  • CAR-T cell therapy research
  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Immune Cell Function and Interaction
  • Chronic Myeloid Leukemia Treatments
  • Cancer Genomics and Diagnostics

John F. DiPersio has been a frequent contributor to several scientific venues. Most notably, they have published extensively in:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Clinical Lymphoma Myeloma & Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)

Their most cited recent papers include:

  • The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia (2023, Nature)
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia (2020, Blood)
  • Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers (2021, New England Journal of Medicine)
  • CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas (2020, Blood)
  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia (2020, Science Translational Medicine)

The scientist has collaborated extensively with other researchers, including frequent coauthors:

  • Michael P. Rettig
  • Julie Ritchey
  • Matthew Cooper
  • Armin Ghobadi
  • Geoffrey L. Uy

John F. DiPersio's work has also been recognized with professional honors such as membership in the Association of American Physicians.

In addition to articles, they have contributed to academic books, including a publication with Springer International Publishing titled Gene and Cellular Immunotherapy for Cancer in 2022.

Best Publications

  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

    Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Daniel W. Lee;Bianca D. Santomasso;Frederick L. Locke;Armin Ghobadi

  • Recurring mutations found by sequencing an acute myeloid leukemia genome.

    Elaine R. Mardis;Li Ding;David J. Dooling;David E. Larson

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

    Li Ding;Timothy J. Ley;David E. Larson;Christopher A. Miller

  • DNMT3A Mutations in Acute Myeloid Leukemia

    Timothy J. Ley;Li Ding;Matthew J. Walter;Michael D. McLellan

  • A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

    Srdan Verstovsek;Ruben A. Mesa;Jason Gotlib;Richard S. Levy

  • Age-related mutations associated with clonal hematopoietic expansion and malignancies

    Mingchao Xie;Charles Lu;Jiayin Wang;Michael D McLellan

  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.

    Hagop Kantarjian;Jean-Pierre J. Issa;Craig S. Rosenfeld M.D.;John M. Bennett

  • The origin and evolution of mutations in acute myeloid leukemia.

    John S. Welch;Timothy J. Ley;Daniel C. Link;Christopher A. Miller

  • DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

    Timothy J. Ley;Elaine R. Mardis;Li Ding;Bob Fulton

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Clonal Architecture of Secondary Acute Myeloid Leukemia

    Matthew J. Walter;Dong Shen;Li Ding;Jin Shao

  • Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

    John F. DiPersio;Ivana N. Micallef;Patrick J. Stiff;Brian J. Bolwell

  • TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    John S. Welch;Allegra A. Petti;Christopher A. Miller;Catrina C. Fronick

  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

    John F. DiPersio;Edward A. Stadtmauer;Auayporn Nademanee;Ivana N.M. Micallef

  • Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

    Terrence N. Wong;Giridharan Ramsingh;Andrew L. Young;Christopher A. Miller

Frequent Co-Authors

Peter Westervelt
Peter Westervelt Brown University
Ravi Vij
Ravi Vij Washington University in St. Louis
Timothy J. Ley
Timothy J. Ley Washington University in St. Louis
Daniel C. Link
Daniel C. Link Washington University in St. Louis
Robert S. Fulton
Robert S. Fulton Washington University in St. Louis
Elaine R. Mardis
Elaine R. Mardis The Ohio State University
Feng Gao
Feng Gao Linköping University
feng gao
feng gao Duke University
Li Ding
Li Ding Washington University in St. Louis
Richard K. Wilson
Richard K. Wilson Nationwide Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine or healthcare? There are several flexible pathways to get started, even if you're looking for online options. Many students today choose to earn a health information management degree online. This degree focuses on the critical intersection of healthcare, technology, and data, preparing graduates for roles in hospitals, clinics, and insurance providers.

If you’re interested in administrative healthcare roles, learning about medical billing and coding certification cost is a great first step. Certification can often be completed quickly and affordably, opening doors to remote and entry-level positions.

Students aiming to become advanced practice nurses may explore the cheapest online fnp program. Family Nurse Practitioner (FNP) programs online are an efficient route for RNs who want to provide primary care.

For those pursuing a more general nursing path, attending nursing school online offers flexibility and lower costs compared to many on-campus programs. These online pathways allow you to join the healthcare workforce while balancing study with work or family commitments.

Best Scientists Citing John F. DiPersio

Trending Scientists